menu search

CELZ / What Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stock

What Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stock
Creative Medical Technology Holdings, Inc. (CELZ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Read More
Posted: Sep 22 2023, 13:31
Author Name: Zacks Investment Research
Views: 110934

CELZ News  

What Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stock

By Zacks Investment Research
September 22, 2023

What Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stock

Creative Medical Technology Holdings, Inc. (CELZ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings more_horizontal

Creative Medical (CELZ) Up 86% on Upbeat Diabetes Study Data

By Zacks Investment Research
April 13, 2023

Creative Medical (CELZ) Up 86% on Upbeat Diabetes Study Data

Creative Medical Technology (CELZ) reports positive one-year follow-up data from a study showing the efficacy of CELZ-001 in treating type II diabetes more_horizontal

Why Is Creative Medical (CELZ) Stock Up 121% Today?

By InvestorPlace
February 8, 2023

Why Is Creative Medical (CELZ) Stock Up 121% Today?

Creative Medical (NASDAQ: CELZ ) stock is rocketing higher on Wednesday thanks to clearance for a new clinical trial. That clearance comes from the FD more_horizontal

Top Must-Watch Penny Stocks For Your April List

By PennyStocks
March 25, 2022

Top Must-Watch Penny Stocks For Your April List

Are these penny stocks on your April watchlist? The post Top Must-Watch Penny Stocks For Your April List  appeared first on Penny Stocks to Buy, Pick more_horizontal

Creative Medical (CELZ) Up 82% on Stem Cell Treatment Data

By Zacks Investment Research
March 24, 2022

Creative Medical (CELZ) Up 82% on Stem Cell Treatment Data

Creative Medical Technology (CELZ) reports positive follow-up data from a pilot study evaluating StemSpine, a patented stem cell treatment for chronic more_horizontal

Why Is Creative Medical Technology (CELZ) Stock Up Today?

By InvestorPlace
March 23, 2022

Why Is Creative Medical Technology (CELZ) Stock Up Today?

Creative Medical Technology announced positive results concerning its StemSpine procedure. Here's what you should know as CELZ stock rises. more_horizontal

Why Creative Medical Technology Shares Are Soaring

By Benzinga
March 23, 2022

Why Creative Medical Technology Shares Are Soaring

Creative Medical Technology Holdings Inc (NASDAQ: CELZ) shares are trading higher Wednesday after the company announced top-line results for its follo more_horizontal

Creative Medical Shares Soar On Positive Data from StemSpine Pilot Study

By Benzinga
March 23, 2022

Creative Medical Shares Soar On Positive Data from StemSpine Pilot Study

Creative Medical Technology Holdings (NASDAQ: CELZ) has announced positive two-year follow-up data from its StemSpine pilot study. more_horizontal


Search within

Pages Search Results: